![](/img/cover-not-exists.png)
730PPhase II trial of trifluridine/tipiracil (TAS-102) in patients with advanced refractory biliary tract cancer (BTC)
Chakrabarti, S, Zemla, T, Ou, F-S, Fruth, B, Ahn, D, Borad, M J, Hartgers, M L, Wessling, J, Walkes, R L, Alberts, S, McWilliams, R R, Liu, M C, Mahipal, AVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.057
Date:
October, 2019
File:
PDF, 78 KB
2019